Home / Stock ratings / VTRS
Stock rating · Pharmaceutical Preparations
Viatris Inc. (VTRS) Stock Rating & Analysis
As of October 13, 2026, MELANY rates Viatris Inc. 75 out of 100 (Highest Conviction). Its highest factor score is catalyst setup at 94, and its lowest is business quality at 42.
MELANY ratingRated 2026-10-13VTRS · composite score
About Viatris Inc.
Viatris was created in November 2020 by combining Upjohn, a Pfizer subsidiary specializing in off-patent drugs, with Mylan, a global generic and specialty drug maker. The combination made Viatris one of the largest generic drug manufacturers in the world, serving over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of total sales; the other 60% comes from legacy products including Lipitor, Norvasc, Lyrica, and Viagra.
Rating as of 2026-10-13 · this is a dated snapshot; the live rating is in the app (Pro, free for 30 days). The price above updates in real time.
Why VTRS scores 75/100
VTRS's 8 factor scores run from 42 to 94, and 3 of them sit above its composite of 75. Here is how VTRS breaks down.
Whether the price looks cheap or expensive against earnings, growth, and peers.
- FCF yield 13.5%
Margins, returns on capital, and balance-sheet strength.
- Gross margin 40%
Direction and relative strength of the recent share-price trend.
- 50-day MA above 200-day (golden cross zone)
History of beating or missing estimates, and where estimates are heading.
- Beat EPS estimates 4 of last 4 quarters
- Avg EPS beat +10%
- Earnings in 23 days (strong beat history)
What Wall Street price targets and revisions are signalling.
- Institutional net buying +4.5%
Near-term events that could move the stock.
- Earnings in 23 days
Upside weighed against volatility and drawdown risk.
How the current rate and market regime suits this kind of company.
How VTRS compares
As of October 14, 2026, Viatris Inc. ranks 2nd of the 15 companies with a MELANY rating page in its SEC industry group (Pharmaceutical Preparations), where the average score is 69.
Key risks for VTRS
- Trading near 52-week high, limited upside without new positive catalyst
- No positive trailing earnings, valuation cannot be anchored to current P/E
Sector and theme context
Viatris Inc. sits in the Healthcare sector theme, which MELANY currently rates 62/100 for strength. Theme strength feeds VTRS's momentum and catalyst factors above.
VTRS trade plan (Pro)
MELANY has a full position plan for Viatris Inc.: a smart entry zone, an alert level, position sizing, and quarterly review triggers. It is part of Market Eyes Pro, and the first 30 days are free.
How MELANY rates VTRS
MELANY is a rules-based engine that scores every stock from 0 to 100 across eight weighted factors, then re-scores as new price, earnings, and fundamental data arrive. Viatris Inc.'s 75/100 reflects speculative factor weighting for its profile. Position framework managed by score-based check-ins, not a fixed holding period.
Ratings are algorithmic and change with the data. They are research and education, not personalized investment advice.
Frequently asked questions about VTRS
Is Viatris Inc. (VTRS) a buy?
As of 2026-10-13, MELANY rated Viatris Inc. Highest Conviction with a composite score of 75/100. That is a dated snapshot, not the live rating, and it is an algorithmic reading built from eight factors rather than personalized investment advice. Review the factor breakdown above and the disclaimer below before making any decision.
What is Viatris Inc.'s MELANY score?
Viatris Inc. (VTRS) has a MELANY composite score of 75/100, combining valuation, business quality, price momentum, earnings track record, analyst sentiment, catalyst setup, risk-adjusted profile, macro fit.
How is the VTRS stock rating calculated?
MELANY scores VTRS from 0 to 100 across eight weighted factors using live market and fundamental data, then refreshes the rating automatically as new data arrives.
Should I buy Viatris Inc. stock?
That decision is yours; Market Eyes Live does not give buy or sell advice. What the data says: MELANY rates Viatris Inc. (VTRS) Highest Conviction with a composite of 75/100 as of 2026-10-13. The factor breakdown above shows what is driving that, which is a better basis for a decision than any one-word verdict.
What is the VTRS stock price forecast?
MELANY does not publish price targets or forecasts for VTRS. Predicting a future price is exactly the kind of false precision the confidence framework avoids. Instead it scores today's setup, 75/100 across eight factors for Viatris Inc., and re-scores automatically as new price, earnings, and fundamental data arrive.
Is VTRS stock overvalued or undervalued?
MELANY's valuation factor currently reads 78/100 for Viatris Inc., where a higher score means the price looks more attractive on that measure. Scores in the 70s and above read as attractively priced, the mid range as roughly fair, and low scores as stretched. The factor breakdown above shows what drives VTRS's read.
What price should I buy VTRS at?
Rather than chasing the current price, MELANY computes a smart entry zone for VTRS: the price area where risk and reward actually favor a new position, plus an alert level and position sizing. The exact levels are part of Market Eyes Pro, which starts with a 30-day free trial.
What are the risks of buying VTRS stock?
The top risks MELANY currently flags for Viatris Inc.: Trading near 52-week high, limited upside without new positive catalyst; No positive trailing earnings, valuation cannot be anchored to current P/E. The rating on this page already weighs these against the bullish factors; see the risk-adjusted profile score in the breakdown above.
Is Viatris Inc. a good long-term investment?
For long-term durability the two factors that matter most are business quality, which MELANY scores 42/100 for Viatris Inc., and earnings track record, at 84/100. The 75/100 composite blends those with six shorter-horizon factors. Durable quality at a fair price is the long-term case to test; this is research, not personalized investment advice.
Will VTRS stock go up?
Nobody can promise a stock's direction, and Market Eyes Live does not predict prices. The measurable part: MELANY's price momentum factor reads 67/100 for VTRS right now, and the catalyst setup factor tracks whether near-term events could move it. Both re-score automatically as the data changes.
How current is this VTRS rating?
The rating on this page is a snapshot of MELANY's read as of 2026-10-13. The price shown updates live, but the score is not recomputed on this page. MELANY re-scores VTRS continuously as new price, earnings, and fundamental data arrive, and the current rating is in the app (Pro, free for 30 days).
How this rating works
Market Eyes Live
Every rating graded in public, VTRS included
MELANY scores more than 11,000 U.S. stocks and ETFs, PRISM ranks conviction and APEX writes the plan with one entry zone. Free to start on iOS and the web.